Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sci Adv ; 5(12): eaaw9051, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31840058

RESUMEN

Epigenetic modifications play critical roles in inducing long-lasting immunological memory in innate immune cells, termed trained immunity. Whether similar epigenetic mechanisms regulate dendtritic cell (DC) function to orchestrate development of adaptive immunity remains unknown. We report that DCs matured with IFNγ and TNFα or matured in the lungs during invasive fungal infection with endogenous TNFα acquired a stable TNFα-dependent DC1 program, rendering them resistant to both antigen- and cytokine-induced alternative activation. TNFα-programmed DC1 had increased association of H3K4me3 with DC1 gene promoter regions. Furthermore, MLL1 inhibition blocked TNFα-mediated DC1 phenotype stabilization. During IFI, TNFα-programmed DC1s were required for the development of sustained TH1/TH17 protective immunity, and bone marrow pre-DCs exhibited TNFα-dependent preprogramming, supporting continuous generation of programmed DC1 throughout the infection. TNFα signaling, associated with epigenetic activation of DC1 genes particularly via H3K4me3, critically contributes to generation and sustenance of type 1/17 adaptive immunity and the immune protection against persistent infection.


Asunto(s)
Polaridad Celular , Citoprotección , Células Dendríticas/metabolismo , Epigénesis Genética , Linfocitos T/citología , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Polaridad Celular/efectos de los fármacos , Reprogramación Celular/efectos de los fármacos , Cryptococcus/efectos de los fármacos , Cryptococcus/fisiología , Citoprotección/efectos de los fármacos , Células Dendríticas/efectos de los fármacos , Epigénesis Genética/efectos de los fármacos , Femenino , N-Metiltransferasa de Histona-Lisina/metabolismo , Histonas/metabolismo , Inmunomodulación/efectos de los fármacos , Lisina/metabolismo , Metilación , Ratones Endogámicos CBA , Proteína de la Leucemia Mieloide-Linfoide/metabolismo , Fenotipo , Regiones Promotoras Genéticas/genética , Supresión Genética/efectos de los fármacos , Linfocitos T/efectos de los fármacos , Células TH1/efectos de los fármacos , Células TH1/inmunología , Factor de Necrosis Tumoral alfa/farmacología
2.
Transl Res ; 204: 39-50, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30392877

RESUMEN

Impaired wound healing is a major secondary complication of type 2 diabetes that often results in limb loss and disability. Normal tissue repair progresses through discrete phases including hemostasis, inflammation, proliferation, and remodeling. In diabetes, normal progression through these phases is impaired resulting in a sustained inflammatory state and dysfunctional epithelialization in the wound. Due to their plasticity, macrophages play a critical role in the transition from the inflammation phase to the proliferation phase. Diabetes disrupts macrophage function by impairing monocyte recruitment to the wound, reducing phagocytosis, and prohibiting the transition of inflammatory macrophages to an anti-inflammatory state. Diabetes also impedes keratinocyte and fibroblast function during the later phases resulting in impaired epithelialization of the wound. Several recent studies suggest that altered epigenetic regulation of both immune and structural cells in wounds may influence cell phenotypes and healing, particularly in pathologic states, such as diabetes. Specifically, it has been shown that macrophage plasticity during wound repair is partly regulated epigenetically and that diabetes alters this epigenetic regulation and contributes to a sustained inflammatory state. Epigenetic regulation is also known to regulate keratinocyte and fibroblast function during wound repair. In this review, we provide an introduction to the epigenetic mechanisms that regulate tissue repair and highlight recent findings that demonstrate, how epigenetic events are altered during the course of diabetic wound healing.


Asunto(s)
Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/fisiopatología , Pie Diabético/fisiopatología , Epigénesis Genética , Cicatrización de Heridas/fisiología , Animales , Plasticidad de la Célula , Ensamble y Desensamble de Cromatina , Metilación de ADN , Fibroblastos/fisiología , Histonas/metabolismo , Humanos , Macrófagos/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA